At StemX Bio, we’re transforming drug discovery with our ready-to-use human pancreas microtissue model. Our innovative approach, backed by a patent-pending differentiation protocol, empowers researchers to rapidly advance from screening to clinical trials. Our human microtissue models offer unmatched predictive value, robustness, and scalability, accelerating the development of effective and safer therapies for diabetes. Join us in shaping the future of medical research and treatment.

StemX Bio

Org chart

Teams

Offices